Zusammenfassung
Die sog. Parapsoriasisgruppe ist eine wenig homogene Gruppe von Hauterkrankungen, die klinisch z. T. mit einer Vaskulitis einhergehen und als hyperergische Hautreaktionen im Anschluss oder in Verbindung mit einer Infektion auftreten (z. B. Pityriasis lichenoides et varioliformis acuta), zum anderen Teil aber als Vorstadien eines kutanen T-Zell-Lymphoms (CTCL) gelten (z.B. Parapsoriasis en plaques). Das Verbindungsglied zwischen beiden stellt die lymphomatoide Papulose dar, deren Definition erst in den 6oer Jahren aus der vaskulitischen Subgruppe heraus erfolgte (Macauley). Dieses Krankheitsbild wird von uns in seinem nosologischen Wert und klinischen Erscheinungbild weiterhin als Pseudo- bzw. Prälymphom aufgefasst, obwohl es in der Klassifikation der European Organization for Research and Treatment of Cancer (EORTC) von 1997 dem Spektrum der CD30 + kutanen T-Zell-Lymphome zugeordnet wird.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Boelen RE, Faber WR, Lambers JCCA et al. (1982) Long-term follow up of photochemotherapy in pityriasis lichenoides. Acta Derm Venereol 62:442–444
Gelmetti C, Rigoni C, Alessi E et al. (1990) Pityriasis lichenoides in children: A long-term follow-up of eighty-nine cases. J Am Acad Dermatol 23: 473–478
Griffiths JK. (1998) Successful long-term use of cyclosporine A in HIV-induced pityriasis lichenoides chronica. J Acquir Immune Defic Syndr Hum Retrovirol 1:396–397
Groisser DS, Griffiths CE, Ellis CN, Voorhees JJ (1991) A review and update of the clinical uses of cyclosporine in dermatology. Dermatol Clin 9: 805–817
Gupta AK, Ellis CN, Nickoloff BJ et al. (1990) Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatosis. Arch Dermatol 126:339–350
Isoda M (1989) Pityriasis lichenoides-like eruption occurring during therapy for myelogenous leukemia. J Dermatol 16:73–75
Klene C, Cony M, Plantin P et al. (1991) Pityriasis lichenoide (parapsoriasis en gouttes) de l’enfant. Ann Pediatr Paris 38:469–475
Le Vine MJ (1983) Phototherapie of pityriasis lichenoides. Arch Dermatol 119:378–380
Lynch PJ, Saied NK (1979) Methotrexate treatment of pityriasis lichenoides and lymphomatoid papulosis. Cutis 23: 634–636
Nassef NE, Hamman MA (1997) The relation between toxoplasmosis and pityriasis lichenoides chronica. J Egypt Soc Parasitol 27:93–99
Panizzon RG, Speich R, Dazzi H (1992) Atypical manifestations of pityriasis lichenoides chronica: development into paraneoplasia and non-Hodgkin lymphomas of the skin. Dermatology 184: 65–69
Romani J, Puig L, Fernandez-Figueras MT, de Moragas JM (1998) Pityriasis lichenoides in children: clinicopathological review of 22 patients. Pediatr Dermatol 15:1–6
Powell FC, Muller SA (1984) Psoralens and ultraviolet A therapy of pityriasis lichenoides. J Am Acad Dermatol 10:59–64
Rogers M (1992) Pityriasis lichenoides and lymphomatoid papulosis. Semin Dermatol 11:73–79
Truhan AP, Herbert AA, Esterly NB (1986) Pityriasis lichenoides in children: Therapeutic response to erythromycin. J Am Acad Dermatol 15: 66–70
Wood GS, Strickler JG, Abel EA et al. (1987) Immunhistology of pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica: Evidence for their interrelationship with lymphomatoid papulosis. J Am Acad Dermatol 16:559–570
Auster BI, Santa Cruz DJ, Eisen AZ (1979) Febrile ulceronecrotic Mucha-Habermann’s disease with interstitial pneumonitis. J Cut Pathol 6: 66–76
Edwards BL, Bonagura VR, Valacer DJ et al. (1989) Mucha-Habermann’s disease and arthritis: possible association with reactivated Epstein-Barr virus infection. J Rheumatol 16:387–389
Ellesworth JE, Cassidy JT, Ragsdale CG et al. (1982) Mucha-Habermann’s disease in children: the association with rheumatic diseases. J Rheumatol 9:319–324
English JC, Collins M, Bryart-Bruce C (1995) Pityriasis lichenoides et varioliformis acuta and group-A beta hemolytic streptoccal infection. Int J Dermatol 34: 642–644
Falcini, F, Bartolozi G, Montanelli F (1987) La malattia di Mucha-Habermann. Descrizione di un caso in eta pediatrica. Pediatr Med Chir 9:343–345
Fortson JS, Schröter AL, Esterly NB (1990) Cutaneous T-cell lymphoma (parapsoriasis en plaques). An association with pityriasis lichenoides et varioliformis acuta in young children. Arch Dermatol 126:1449–1453
Franc MP, Barrut D, Moulin G (1980) Le parapsoriasis en gouttes. Ann Dermatol Venereol 107: 895–899
Gelmetti C, Rigoni C, Allessi E et al. (1990) Pityriasis lichenoides in children: a long-term follow-up in eighty-nine cases. J Am Acad Dermatol 23: 473–478
Gritiyarangsan P, Pruen Glampoo S, Ruangratanarote P (1987) Comparative studies of treatments for pityriasis lichenoides. J Dermatol 14: 258–261
Levine MJ (1983) Phototherapy of pityriasis lichenoides. Arch Dermatol 119:378–380
Longley J, Demar L, Feinstein RP et al. (1987) Clinical and histologic features of pityriasis lichenoides et varioliformis acuta in children. Arch Dermatol 123: 1335–1339
Luberti AA, Rabinowitz LG, Ververeli KO (1991) Severe febrile Mucha-Habermann’s disease in children: case report and review of the literature. Pediatr Dermatol 8: 51–57
Lynch PJ, Saied NK (1979) Methotrexate treatment of pityriasis lichenoides and lymphomatoid papulosis. Cutis 23: 634–636
Panhans A, Bodemer C, Macinthyre E, Freitag S, Paul C, Prost Y de (1996) Pityriasis lichenoides of childhood with atypical CD30-positive cells and clonal T-cell receptor gene rearrangement. J Am Acad Dermatol 35: 489–490
Phiamphongsant T (1974) Tetracycline for the treatment of pityriasis lichenoides. Br J Dermatol 91:319–322
Powell FC, Muller SA (1984) Psoralens and ultraviolet. A therapy of pityriasis lichenoides. J Am Acad Dermatol 10:59–64
Romani J, Puig L, Fernandez-Figueras MT, Moragas JM de (1998) Pityriasis lichenoides in children: clinicopathological review of 22 patients. Pediatr. Dermatol 15: 1–6
Rongioletti F, Rivara G, Rebora A (1987) Pityriasis lichenoides et varioliformis acuta and aquired toxoplasmosis. Dermatologica 175: 41–44
Sauer GC (1985) Pentoxifylline (Torental) therapy for vasculitis of pityriasis lichenoides and varioliformis. Arch Dermatol 121:1487
Sharin JS, Jones AT, Aton JK et al. (1978) Mucha Habermann’s disease in children. Treatment with erythromycin. Arch Dermatol 114:1679–1680
Tham SN (1985) UVB phototherapy for pityriasis lichenoides. Aust J Dermatol 26:9–13
Thivolet J, Ortonne JP, Gianadda B et al. (1981) Photochimiothérapie orale du parapsoriasis en gouttes. Dermatol 163: 12–18
Varga FJ, Vonderheid EC, Olbricht SM, Kadin ME (1990) Immunohistochemical distinction of lymphomatoid papulosis and pityriasis lichenoides et varioliformis acuta. Am J Pathol 136:979–987
Weiss LM, Wood GS, Ellisen LW et al. (1987) Clonal T-cell populations in pityriasis lichenoides et varioliformis acuta (Mucha-Habermann disease). Am J Pathol 126:417–421
Burg G, Dummer R, Nestle FO, Doebbeling U, Haeffner A (1996) Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungo-ides and small plaque parapsoriasis. Arch Dermatol 132: 567–571
Claudy AL, Rouchouse B, Boucheron S et al. (1983) Treatment of cutaneous lymphoma with etretinate. Br J Dermatol 109:49–56
Haeffner AC, Smoller BR, Zepter K, Wood GS (1995) Differentiation and clonality of lesionai lymphocyts in small plaque parapsoriasis. Arch Dermatol 131:321–324
Hofer A, Cerroni L, Kerl H et al. (1999) Narrowband (311 nm) UVB-therapy for small plaque parapsoriasis and early-stage mycosis fungoides. Arch Dermatol 135:1377–1380
Lasar AP, Caro WA, Roenigk HH, Pinski KS (1989) Parapsoriasis and mycosis fungoides: the Northestern University experience, 1970–1985. J Am Acad Dermatol 21: 919–923
Fortson JS, Schröter AL, Esterley NB (1990) Cutaneous T-cell lymphoma (parapsoriasis en plaques). An association with pityriasis lichenoides et varioliformis acuta in young children. Arch Dermatol 126: 1449–1453
Kikuchi A, Naka W, Harada T et al. (1993) Parapsoriasis en plaques: its potential for progression to malignant lymphoma. J Am Acad Dermatol 29: 419–422
Milstein HJ, Vonderheid EC, Van Scott EJ et al. (1982) Home ultraviolet phototherapy of early mycosis fungoides preliminary observations. J Am Acad Dermatol 6:335–362
Powell FC, Spiegel GT, Muller SA (1984) Treatment of parapsoriasis and mycosis fungoides: the role of psoralen and long-wave ultraviolet light A (PUVA). Mayo Clin Proc 59: 538–546
Ramsay DL, Halperin PS, Zeleniuch-Jacquotte A (1988) Topical mechlorethamine therapy for early stage mycosis fungoides. J Am Acad Dermatol 19: 684–691
Roenigk HH Jr, Kuzel TM, Skontelis AP et al. (1990) Photochemotherapy alone or combined with interferon alpha2a in the treatment of cutaneous T-cell lymphoma. J Invest Dermatol 95:198–205
Samman PD (1975) Cutaneous reticuloses. Trans St Johns Hosp Derm Soc 61:11–13
Souteyrand P, Thivolet J, Fulton R (1981) Treatment of parapsoriasis en plaques and mycosis fungoides with an oral aromatic retinoid (Ro 10–9359). In: Orfanos CE (ed) Retinoids. Springer, Berlin Heidelberg New York, pp 313–316
Tay YK (1996) Experience with UVB phototherapy in children. Pediatr Dermatol 13:406–409
Basarab T, Fraser-Andrews EA, Orchard G et al. (1998) Lymphomatoid papulosis in association with mycosis fungoides. A study of 15 cases. Br J Dermatol 139:630–638
Baumgartner G, Duschet P, Schwarz T et al. (1986) Lymphomatoid papulosis: remission following intravenously administered acyclovir. Dermatol 172:305–309
Beljaards RC, Willemze R (1992) The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas. Br. J Dermatol 126:596–602
Blondeel A, Knitelius AC, De Coninck A et al. (1982) Papulose lymphomatoide ameliorée par PUVA therapie. Dermatologica (Basel) 165:466–468
Burg G, Klepzig K, Klaudewitz P et al. (1986) Acyclovir in lymphomatoid papulosis and mycosis fungoides. JAMA 256: 214–215
Cockerell CJ, Stetler LD (1991) Accuracy in diagnosis of lymphomatoid papulosis. Am J Dermatopathol 13:20–25
Demierre M-F, Goldberg LJ, Kadin ME, Koh HK (1997) Is it lymphoma or lymphomatoid papulosis? J Am Acad Dermatol 36:765–772
Erpaiboon P, Mihara I, Niimura M et al. (1991) Lymphomatoid papulosis: clinicopathological comparative study with pityriasis lichenoides et varioliformis acuta. J Dermatol 18:580–585
Everett MA (1984) Treatment of lymphomatoid papulosis with methotrexate. Br J Dermatol 111: 631
Hofer A, Cerroni L, Kerl H et al. (1999) Narrowband (311 nm) UVB-therapy for small plaque parapsoriasis and early-stage mycosis fungoides. Arch Dermatol 135:1377–1380
Karp DL, Horn TD (1994) Lymphomatoid papulosis. J Am Acad Dermatol 30:379–395
Kato N, Tornita Y, Yoshida K, Hisai H (1998) Involvement of the tongue by lymphomatoid papulosis. Am J Dermatopathol 20:522–526
Kaudewitz P, Burg G (1991) Lymphomatoid papulosis and Ki-1 (CD30)-positive cutaneous large cell lymphomas. Semin Diagn Pathol 8:117–124
Kaudewitz P, Stein H, Burg G (1986) Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1. J Invest Dermatol 86:350–354
Lange-Wantzin G, Thomsen K (1982) PUVA-treatment in lymphomatoid papulosis. Br J Dermatol 107: 687–690
Lange-Wantzin G, Thomsen K (1984) Methotrexate in lymphomatoid papulosis. Br J Dermatol 111:93–95
Lynch PJ, Saied NK (1979) Methotrexate treatment of pityriasis lichenoides and lymphomatoid papulosis. Cutis 23: 634–636
Macaulay WL (1968) Lymphomatoid papulosis: a continuing self-healing eruption, clinically benign-histologically malignant. Arch Dermatol 97: 23–30
Milde P, Goerz G, Lehmann P (1993) Lymphomatoid papulosis in a child. Hautarzt 44: 674–679
Parks JD, Synovec MS, Masih AS et al. (1992) Immunophenotypic and genotypic characterization of lymphomatoid papulosis. J Am Acad Dermatol 26:968–975
Paul MA, Krowchuk DP, Hitchcock MG, Jorizzo JL (1996) Lymphomatoid papulosis: successful weekly pulse superpotent topical corticoid therapy in three pediatric patients. Pediatr Dermatol 13:501–506
Schmuth M, Topar G, Illersperger B et al. (2000) Therapeutic use of interferon-alpha for lymphomatoid papulosis. Cancer 89:1603–1610
Siddiqui MA, Sullivan S, Mofadhi M (1997) Lymphomatoid papulosis and FK 506. Int J Dermatol 36: 205–204
Silva NM, Morais JC, Spector N, Maceira J, Sousa MA, Filgueira AL (1998) Lymphomatoid papulosis followed by Hodgkin’s disease. Int J Dermatol 37:541–543
Thomsen K, Lange-Wantzin G (1987) Lymphomatoid papulosis. A follow-up study of 30 patients. J Am Acad Dermatol 17: 632–636
Trautmann Ch, Hahnemann HG, Hilbert ET et al. (1995) Das großzellig-anaplastische Ki-1-positive Lymphom der Haut. Hautarzt 46:28–34
Whittaker S, Smith N, Jones RR, Luzzatto L (1991) Analysis of beta, gamma and delta T-cell receptor genes in lymphomatoid papulosis: cellular basis of two distinct histologic subsets. J Invest Dermatol 96: 786–791
Willemze R, Beljaards RC (1992) Spectrum of primary cutaneous CD30 (Ki-1-)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 28: 973–980
Willemze R, Meijer CJLM, Vloten WA van, Scheffer E (1982) The clinical and histological spectrum of lymphomatoid papulosis. Br J Dermatol 107:131–144
Willemze R, Kerl H, Sterry W et al. (1997) EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the european organisation for research and treatment of cancer. Blood 90:354–371
Wollina U (1998) Lymphomatoid papulosis treated with extracorporeal photochemotherapy. Oncol Rep 5: 57–59
Wyss M, Dummer R, Dommann SN, Joller-Jemelka HI, Dours-Zimmermann MT, Gilliet F, Burg G (1995) Lymphomatoid papulosis- treatment with recombinant interferon alfa-2a and etretinate. Dermatology 190:288–291
Zackheim HS, Epstein EH, Crain WR (1985) Topical carmustine therapy for lymphomatoid papulosis. Arch Dermatol 121:1410–1414
Ahmed I, Charles-Holmes R (2000) Localized Pityriasis rosea. Clin Exp Dermatol 25: 624–626
Bigby M (2000) A remarkable result of a double-masked, placebo-controlled trial of erythromycin in the treatment of pityriasis rosea. Arch Dermatol 136:775–776
Kempf W, Burg G (2000) Pityriasis rosea. A virus-induced skin disease? An update. Arch Virol 145:1509–1520
Leenutaphong V, Jiamton S (1995) UVB phototherapy for pityriasis rosea. A bilateral comparison study. J Am Acad Dermatol 33:996–999
Sharma PK, Yadav TP, Gautam PK et al. (2000) Erythromycin in pityriasis rosea. A double-blind, placebo-controlled clinical trial. J Am Acad Dermatol 42:241–244
Pierson JC, Dijkstra WE, Elston DM (1993) Purpuric pityriasis rosea. J Am Acad Dermatol 28:1021
Spelman LJ, Robertson IM, Strutton GM, Weedon D (1994) Pityriasis rosea-like eruption after bone marrow transplantation. J Am Acad Dermatol 31:348–351
Vidimos AT, Camisa C (1992) Tongue and cheek: oral lesions in pityriasis rosea. Cutis 50: 276–280
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Orfanos, C.E., Garbe, C. (2002). Die Parapsoriasisgruppe und Verwandtes. In: Blume-Peytavi, U., et al. Therapie der Hautkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56219-8_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-56219-8_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62541-1
Online ISBN: 978-3-642-56219-8
eBook Packages: Springer Book Archive